Corvus Pharmaceuticals, Inc.
CRVS$1.33B
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaBURLINGAME31 employees
Drugs in Pipeline
1
Phase 3 Programs
1
Upcoming Catalysts
1
Next Catalyst
Nov 15, 2026
35wMarket Overview
Stock performance and key metrics
CRVS News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Soquelitinib | Phase 3 | Peripheral T-Cell Lymphoma, Not Otherwise Specified | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply